BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17294127)

  • 21. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Morita H; Suzuki G; Mishima T; Chaudhry PA; Anagnostopoulos PV; Tanhehco EJ; Sharov VG; Goldstein S; Sabbah HN
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):443-9. PubMed ID: 12652114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure.
    Cha YM; Redfield MM; Shah S; Shen WK; Fishbein MC; Chen PS
    Heart Rhythm; 2005 Sep; 2(9):984-90. PubMed ID: 16171755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
    Sabbah HN; Stanley WC; Sharov VG; Mishima T; Tanimura M; Benedict CR; Hegde S; Goldstein S
    Circulation; 2000 Oct; 102(16):1990-5. PubMed ID: 11034950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
    Tarkia M; Stark C; Haavisto M; Kentala R; Vähäsilta T; Savunen T; Strandberg M; Saunavaara V; Tolvanen T; Teräs M; Pietilä M; Nyman L; Duvall E; Saukko P; Levijoki J; Roivainen A; Saraste A; Knuuti J
    Heart; 2016 Mar; 102(6):465-71. PubMed ID: 26762238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.
    Duerr RL; Huang S; Miraliakbar HR; Clark R; Chien KR; Ross J
    J Clin Invest; 1995 Feb; 95(2):619-27. PubMed ID: 7860746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction.
    Frantz S; Hu K; Widder J; Bayer B; Witzel CC; Schmidt I; Galuppo P; Strotmann J; Ertl G; Bauersachs J
    Br J Pharmacol; 2004 Jan; 141(1):9-14. PubMed ID: 14662734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
    Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
    J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
    Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.
    Brower GL; Janicki JS
    J Card Fail; 2005 Sep; 11(7):548-56. PubMed ID: 16198252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors.
    Goldstein S; Sharov VG; Cook JM; Sabbah HN
    Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):51-5. PubMed ID: 7494555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats.
    Ciobotaru V; Heimburger M; Louedec L; Heymes C; Ventura-Clapier R; Bedossa P; Escoubet B; Michel JB; Mercadier JJ; Logeart D
    J Pharmacol Exp Ther; 2008 Jan; 324(1):43-9. PubMed ID: 17901295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
    Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CVT-4325 inhibits myocardial fatty acid uptake and improves left ventricular systolic function without increasing myocardial oxygen consumption in dogs with chronic heart failure.
    Imai M; Rastogi S; Sharma N; Chandler MP; Sharov VG; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
    Cardiovasc Drugs Ther; 2007 Feb; 21(1):9-15. PubMed ID: 17119875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term carperitide treatment attenuates left ventricular remodeling in rats with heart failure after autoimmune myocarditis.
    Tanaka K; Ito M; Kodama M; Hoyano M; Kimura S; Mitsuma W; Hirono S; Adachi T; Watanabe K; Nakazawa M; Aizawa Y
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):232-9. PubMed ID: 19668089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
    Lionetti V; Linke A; Chandler MP; Young ME; Penn MS; Gupte S; d'Agostino C; Hintze TH; Stanley WC; Recchia FA
    Cardiovasc Res; 2005 Jun; 66(3):454-61. PubMed ID: 15914110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.
    Rastogi S; Mishra S; Gupta RC; Sabbah HN
    Heart Fail Rev; 2005 Jun; 10(2):157-63. PubMed ID: 16258723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.